YHYujing Huang

Yujing Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yujing Huang has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Junxia Zheng

    School of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou China

    8 shared publications
  • Duntao Zu

    School of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou P.R. China

    5 shared publications
  • Jianni Yang

    College of Pharmacy Jinan University Guangzhou P.R. China

    5 shared publications
  • Chengyin Huang

    School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, PR China

    3 shared publications
  • Chenjing Tian

    School of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou P.R. China

    3 shared publications
  • Juntao Xie

    School of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou P. R. China

    3 shared publications

Latest Publications

  • Open Access

    Magnetic Bead‐Based Ligand Fishing Identifies SARS‐CoV‐2 Main Protease Inhibitors From Reynoutria japonica

    by Yujing Huang, Chenjing Tian, Zhipeng Gu, Jinlian Liang, Duntao Zu, Jianni Yang, Wanrong Zhang, Nina Ren, Junxia Zheng

    Traditional Chinese medicines (TCMs) are rich sources of structurally diverse bioactive compounds, yet rapid identification of protease inhibitors from complex botanical matrices remains challenging. Here, a magnetic bead‐based affinity‐fishing platform coupled with UPLC‐Q‐Exactive‐Orbitrap‐MS/MS was applied to identify SARS‐CoV‐2 main protease (M pro ) inhibitors from Reynoutria japonica . The crude ethanolic extract inhibited M pro with an IC 50 of 44.92 ± 2.31 µg/mL. M pro ‐functionalized magnetic beads enriched eight constituents, which were identified by high‐resolution mass spectrometry and evaluated using a FRET‐based inhibition assay. Six compounds showed concentration‐dependent activity, with resveratrol being the most potent (IC 50 = 34.01 ± 1.67 µmol/L), followed by glycitein, genistein, emodin, apigenin‐7‐ O ‐glucoside, and biochanin A. HPLC‐DAD further quantified the principal active constituents. Molecular docking suggested interactions with residues in the Mpro substrate‐binding pocket, while network pharmacology predicted associations with host‐related targets involving IL6, TNF, and AKT1. Overall, this workflow enables efficient enrichment, structural identification, and functional prioritization of M pro ‐inhibitory constituents from complex botanical extracts, providing a practical strategy for target‐directed natural product discovery.

  • Open Access

    Structure-Guided Covalent Design and Biological Evaluation of Glycidamido-Leucinamide Antivirulence Agents Against Pseudomonas aeruginosa

    by Xiaoqing Mu, Yujing Huang, Haoming Chen, Xiaojie Huang, Congzhen Shen, Shengrong Li, Junxia Zheng

    Antimicrobial resistance in Pseudomonas aeruginosa has intensified the need for therapies that do not rely solely on bactericidal activity. Antivirulence agents attenuate pathogenic functions and may complement conventional antibiotics. The elastase LasB is a major quorum-sensing (QS)-controlled virulence factor of P. aeruginosa. Starting from the validated N-aryl/α-isobutyl recognition motif of LasB inhibitors, we used an integrated computational workflow combining chemical-space mapping of known LasB inhibitors, focused covalent-library enumeration, and Glu141-directed covalent docking to design glycidamide analogues bearing an epoxide-containing motif. Two compounds were synthesised and characterised, QSI-1 (4-(trifluoromethyl)phenyl) and QSI-2 (4-fluorophenyl), forming a matched molecular pair that differs only at the para substituent. Both compounds inhibited biofilm formation at sub-micromolar concentrations (QSI-1, IC50 = 0.28 μM; QSI-2, IC50 = 0.51 μM) and directly inhibited purified recombinant LasB, with IC50 values of 2.98 μM and 10.20 μM, respectively. Both also preferentially reduced lasB promoter activity relative to the rhlA and pqsA reporters. QSI-1, selected for further evaluation, reduced virulence-factor production and surface-associated motility without measurably inhibiting bacterial growth. QSI-1 enhanced the activity of azithromycin in vitro, and the combination of QSI-1 (25 μM) with azithromycin (0.05 μg/mL) accelerated wound closure and reduced bacterial burden in a murine excisional wound-infection model. QSI-1 showed low cytotoxicity toward mammalian cells at concentrations up to 200 μM. These findings identify QSI-1 and QSI-2 as covalently designed LasB-active antivirulence leads, while direct experimental confirmation of Glu141 covalent modification remains to be established.

  • Discovery of thiol-reactive Staphylococcus aureus sortase A inhibitors from natural products by machine learning and thiocholine mass-shift profiling

    by Yujing Huang, Congzhen Shen, Xiaoqing Mu, Chengyin Huang, Shasha Zhao, Jinlian Liang, Zhipeng Gu, Yingxin Zhang, Zezhong Yang, Jianni Yang, et al.

  • Chemical Characterization, Network Pharmacology, Molecular Docking, and Comparative Anti‐Colitic Activity of Polar and Nonpolar Fractions From Raphanus Sativus L. Seeds

    by Wenlin Chen, Yujing Huang, Xin Yu, Duntao Zu, Tingxin Zhang, Laiyu Tang, Xinbo He, Chengyin Huang, Juntao Xie, Jianni Yang, et al.

    The bioactive material basis of Raphanus sativus L. seeds ( Raphani Semen ) against ulcerative colitis (UC) remains unclear. This study compared the chemical profiles and anti‐colitic efficacy of its nonpolar volatile oil (RSO) and polar ethanol extract (RSEE). Chemical profiling using GC‐MS and UPLC‐MS/MS revealed RSO was dominated by phytosterols, whereas RSEE was enriched in phenolic alkaloids, particularly sinapine. In a dextran sulfate sodium (DSS)‐induced murine colitis model, RSEE demonstrated superior efficacy in reducing disease activity and restoring mucosal barriers compared to RSO. Biochemically, RSEE significantly suppressed myeloperoxidase (MPO) and pro‐inflammatory cytokines while enhancing antioxidant defense. Molecular docking confirmed sinapine as a pivotal compound with high binding affinity for MPO and Keap1. Consequently, the polar fraction is identified as the primary active component, with sinapine serving as the key material basis for treating colitis via oxidative stress modulation.

  • Open Access

    Raphani Semen Extract Targets the las Quorum Sensing System to Suppress Pseudomonas aeruginosa Biofilm and Signal Molecule Production

    by Juntao Xie, Yujing Huang, Honggeng Chen, Zhiyun Xia, Likang Wang, Xin Yu, Jianni Yang, Jun Xu, Hongxia Fan, Junxia Zheng

    Raphanus sativus L. seeds (Raphani Semen, RS) are traditionally used in Chinese medicine for respiratory and gastrointestinal disorders. Pseudomonas aeruginosa ( P . aeruginosa ) biofilm formation and quorum sensing (QS)‐regulated behaviors contribute significantly to its persistence and resistance, highlighting the need for novel QS‐targeting agents. This study aimed to investigate whether RS extract (RSE) and its characteristic constituents sulforaphane (SFA) and sulforaphene (SFE) inhibit P. aeruginosa biofilm and virulence by targeting specific QS pathways. Using sub‐inhibitory concentrations of RSE (≤ 256 μg/mL), SFA and SFE (12.5–100 μM), we evaluated their effects on biofilm formation, bacterial motility, virulence factor production, and signal molecule levels, combined with fluorescent reporter assays, qRT‐PCR, and UPLC‐Q‐Orbitrap‐MS/MS for mechanistic and phytochemical analysis. Results showed that RSE suppressed biofilm formation by 50.93%, impaired motility, and reduced 3‐oxo‐C12‐HSL production. It downregulated key QS genes ( lasR , lasA , lasB , pqsA , and pqsR ) and inhibited lasB / pqsA reporter activity. Phytochemical analysis identified 71 components, and subsequent validation showed that SFA and SFE replicated these effects and exhibited broader QS inhibition across the las , pqs , and rhl systems. SFA (100 μM) demonstrated particularly strong efficacy, suppressing 3‐oxo‐C12‐HSL by 74.29%. Molecular docking indicated that SFA and SFE can bind to LasB, RhlA, and PqsA, albeit with modest affinities. These findings demonstrate that RSE and its active components, SFA and SFE, are potent QS inhibitors that attenuate P. aeruginosa pathogenicity primarily by disrupting the las system, suggesting their potential as natural anti‐biofilm agents that may target multiple components of the QS system.

  • Open Access

    Machine learning-driven discovery of aniline phenylacetate derivatives as LasR-targeted biofilm inhibitors against Pseudomonas aeruginosa infections

    by Yujing Huang, Haoming Chen, Jiamin Wu, Xiaojie Huang, Yingxin Zhang, Anmin Ren, Xiao Wu, Chengyin Huang, Wenguan Xie, Duntao Zu, et al.


  • Development of a magnetic beads-based ligand fishing method for screening SARS-CoV-2 NSP5 inhibitors from complex herbal mixtures: Rosmarinus officinalis as a case study

    by Yujing Huang, Duntao Zu, Chenjing Tian, Juntao Xie, Wenlin Chen, Hongxia Fan, Xin Yu, Huiqing Lu, Jianni Yang, Fulong Lin, et al.


  • Dual Assay Validation of Rosmarinus officinalis Extract as an Inhibitor of SARS‐CoV‐2 Spike Protein: Combining Pseudovirus Testing, Yeast Two‐Hybrid, and UPLC‐Q Exactive Orbitrap‐MS Profiling

    by Yujing Huang, Rufeng Luo, Chenjing Tian, Duntao Zu, Jianni Yang, Wenlin Chen, Dingqiang Huang, Siyan Duan, Shunxin Yan, Yujia Yuan, et al.

    Introduction: This study evaluates the effectiveness of Traditional Chinese Medicine (TCM) extracts in blocking the interaction between the SARS‐CoV‐2 Spike protein and human ACE2 receptor, utilizing a dual‐method approach to explore the antiviral potential of natural compounds.Objectives: This work aims to evaluate the capability of TCM extracts in inhibiting the SARS‐CoV‐2 Spike protein and ACE2 receptor interaction using advanced biochemical assays.Methods: A dual‐method screening approach was utilized, beginning with a pseudovirus assay to assess the inhibition capabilities of TCM extracts in vitro, followed by a split‐ubiquitin yeast two‐hybrid (Y2H) system to validate interactions in live cells. Active compounds were characterized and quantified using UPLC‐Q‐Exactive‐Orbitrap‐MS.Results: Among the 91 TCM extracts tested, Rosmarinus officinalis exhibited the most potent inhibition in both pseudovirus and Y2H assays, significantly reducing viral entry and disrupting the Spike–ACE2 interaction. Comprehensive chemical profiling via UPLC‐Q‐Exactive‐Orbitrap‐MS identified 132 compounds, including phenolics, flavonoids, and terpenoids.Conclusion: This research validates the use of TCM extracts in viral inhibition strategies, demonstrating the utility of integrating traditional remedies with modern scientific approaches to discover new therapeutic agents.